TY - JOUR
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - COVID-19/epidemiology
KW - Humans
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy
KW - Pandemics
KW - Primary Health Care/organization & administration
KW - Rural Health Services/organization & administration
KW - SARS-CoV-2
KW - Telemedicine/organization & administration
KW - United States/epidemiology
KW - COVID-19
KW - buprenorphine/naloxone
KW - opioid use disorder
AU - C. G. Wilson
AU - M. Ramage
AU - E. B. Fagan
A1 - 
AD - University of North Carolina (UNC) Health Sciences at Mountain Area Health Education Center (MAHEC), Asheville, North Carolina.; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina.; School of Medicine, University of North Carolina, Chapel Hill, North Carolina.; MAHEC Obstetrics and Gynecology, Asheville, North Carolina.; University of North Carolina (UNC) Health Sciences at Mountain Area Health Education Center (MAHEC), Asheville, North Carolina.; School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
BT - The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association
C5 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
CP - 1
DO - 10.1111/jrh.12438
IS - 1
JF - The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association
LA - eng
M1 - Journal Article
PY - 2021
SN - 1748-0361; 0890-765X; 0890-765X
SP - 169
EP - 171
EP - 
T1 - A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder
T2 - The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association
TI - A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder
U1 - Education & Workforce; Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U2 - 32277732
U3 - 10.1111/jrh.12438
VL - 37
VO - 1748-0361; 0890-765X; 0890-765X
Y1 - 2021
Y2 - Jan
ER -